The impact of budesonide inhalation suspension for asthma hospitalization: In terms of length of stay, recovery time from symptoms, and hospitalization costs

Background: Hospitalization is a major cause of medical expenditure for asthma. Budesonide inhalation suspension (BIS) may assist in reducing asthma-related symptoms in severe asthma exacerbation. However, its effectiveness for hospitalized patients remains poorly known. The objective of this study...

Descripció completa

Dades bibliogràfiques

Autors principals:	Keima Ito, Yoshihiro Kanemitsu, Kensuke Fukumitsu, Yoshitsugu Inoue, Hirono Nishiyama, Sayaka Yamamoto, Yuki Kitamura, Ryota Kurokawa, Norihisa Takeda, Satoshi Fukuda, Takehiro Uemura, Tomoko Tajiri, Osamu Takakuwa, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Akio Niimi
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2020-10-01
Col·lecció:	Allergology International
Matèries:	Budesonide inhalation suspension Hospitalization costs Length of hospital stay Respiratory infection Severe asthma exacerbation
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1323893020300538
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!